UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000021074 |
|---|---|
| Receipt number | R000024288 |
| Scientific Title | The changes in visual function after intravitreal bevacizmab for ocular neovascular diseases |
| Date of disclosure of the study information | 2016/02/17 |
| Last modified on | 2016/03/08 08:32:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The changes in visual function after intravitreal bevacizmab for ocular neovascular diseases
Acronym
The changes in visual function after intravitreal bevacizmab for ocular neovascular diseases
Scientific Title
The changes in visual function after intravitreal bevacizmab for ocular neovascular diseases
Scientific Title:Acronym
The changes in visual function after intravitreal bevacizmab for ocular neovascular diseases
Region
| Japan |
Condition
Condition
Ocular neovascular diseases
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To assess the efficacy and safety of intravitreal bevacizmab for ocular neovascular diseases
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Visual acuity and Activity of ocular neovascularization for 24 months after injection
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
One or more intravitreal bevacizmab.
The dose is 1.25mg.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Ocular neovascular diseases
Key exclusion criteria
Ocular non-neovascular diseases
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Taiji Sakamoto |
Organization
Kagoshima university
Division name
Ophthalmology
Zip code
Address
8-35-1 Sakuragaoka, Kagoshima 890-8520
TEL
+81-99-275-5402
tsakamot@m3.kufm.kagoshia-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hiroki Otsuka |
Organization
Kagoshima university
Division name
Ophthalmology
Zip code
Address
8-35-1 Sakuragaoka, Kagoshima 890-8520
TEL
+81-99-275-5402
Homepage URL
otsuka-@m2.kufm.kagoshia-u.ac.jp
Sponsor or person
Institute
Ophthalmology, Kagoshima university
Institute
Department
Personal name
Funding Source
Organization
Ophthalmology, Kagoshima university
Organization
Division
Category of Funding Organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 02 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2012 | Year | 12 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 12 | Month | 28 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2016 | Year | 02 | Month | 17 | Day |
Last modified on
| 2016 | Year | 03 | Month | 08 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024288
